These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 18926113)

  • 1. Report on the measles situation in Portugal.
    Gíria M; Rebelo-de-Andrade H; Fernandes T; Pedro S; Freitas G
    Euro Surveill; 2008 Oct; 13(42):. PubMed ID: 18926113
    [No Abstract]   [Full Text] [Related]  

  • 2. European Immunization Week 2008--time for reflection.
    Kreidl P; Gomes H; Lopalco PL; Hagmaier K; Pastore Celentano L; Vasconcelos P; Yilmaz C
    Euro Surveill; 2008 Apr; 13(16):. PubMed ID: 18768124
    [No Abstract]   [Full Text] [Related]  

  • 3. MMR vaccination: new thought.
    Deshmukh V
    Indian Pediatr; 2006 Jun; 43(6):555-6. PubMed ID: 16820670
    [No Abstract]   [Full Text] [Related]  

  • 4. Measles and mumps immunity in Northern Greece, 2004-2007.
    Fylaktou A; Haidopoulou K; Goutaki M; Papadimitriou E; Kalamitsiou S; Papaventsis D
    Euro Surveill; 2008 Apr; 13(16):. PubMed ID: 18768118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measles: making a comeback?
    Nursing; 2010 Jul; 40(7):67. PubMed ID: 20548212
    [No Abstract]   [Full Text] [Related]  

  • 6. European Immunization Week 2008: progress towards regional goals.
    WHO Regional Office for Europe
    Euro Surveill; 2008 Apr; 13(16):. PubMed ID: 18768123
    [No Abstract]   [Full Text] [Related]  

  • 7. Measles--Puerto Rico, 1993, and the measles elimination program.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1994 Mar; 43(9):171-3. PubMed ID: 8164642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ongoing outbreak of measles in Oslo, Norway, January-February 2011.
    Vainio K; Rønning K; Steen TW; Arnesen TM; Anestad G; Dudman S
    Euro Surveill; 2011 Feb; 16(8):. PubMed ID: 21371412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measles immunization in Saudi Arabia: the need for change.
    Khalil MK; Al-Mazrou YY; Al-Jeffri M; Al-Ghamdy YS
    East Mediterr Health J; 2001; 7(4-5):829-34. PubMed ID: 15332786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained measles elimination in Australia and priorities for long term maintenance.
    Gidding HF; Wood J; MacIntyre CR; Kelly H; Lambert SB; Gilbert GL; McIntyre PB
    Vaccine; 2007 May; 25(18):3574-80. PubMed ID: 17300858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sero-epidemiology of measles and mumps in Korea: impact of the catch-up campaign on measles immunity.
    Kim SS; Han HW; Go U; Chung HW
    Vaccine; 2004 Dec; 23(3):290-7. PubMed ID: 15530670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measles once again endemic in the United Kingdom.
    Euro Surveill; 2008 Jul; 13(27):. PubMed ID: 18761933
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunise Australia program: measles control campaign.
    Commun Dis Intell; 1998 Aug; 22(8):156. PubMed ID: 9735549
    [No Abstract]   [Full Text] [Related]  

  • 14. Supplementary immunization activities to achieve measles elimination: experience of the European Region.
    Khetsuriani N; Deshevoi S; Goel A; Spika J; Martin R; Emiroglu N
    J Infect Dis; 2011 Jul; 204 Suppl 1():S343-52. PubMed ID: 21666183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of a novel way to communicate information about MMR on uptake of MMR vaccine: a randomized controlled trial.
    Porter-Jones G; Williams S; Powell C; Pusey L; Roberts RJ
    Public Health; 2009 Jan; 123(1):78-80. PubMed ID: 19081119
    [No Abstract]   [Full Text] [Related]  

  • 16. Measles resurgence in Belgium from January to mid-April 2011: a preliminary report.
    Sabbe M; Hue D; Hutse V; Goubau P
    Euro Surveill; 2011 Apr; 16(16):. PubMed ID: 21527134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rubella elimination programme strengthened through measles elimination programme in Catalonia.
    Domínguez A; Torner N; Martínez A; Costa J; Plans P; Ciruela P; Salleras L
    Vaccine; 2006 Feb; 24(9):1433-7. PubMed ID: 16226357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progress toward implementation of a second-dose measles immunization requirement for all schoolchildren in the United States.
    Kolasa MS; Klemperer-Johnson S; Papania MJ
    J Infect Dis; 2004 May; 189 Suppl 1():S98-103. PubMed ID: 15106097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. When, and how, should we introduce a combination measles-mumps-rubella (MMR) vaccine into the national childhood expanded immunization programme in South Africa?
    Cameron NA
    Vaccine; 2012 Sep; 30 Suppl 3():C58-60. PubMed ID: 22939023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamics and control of measles in Portugal: accessing the impact of anticipating the age for the first dose of MMR from 15 to 12 months of age.
    Paulo AC; Gomes MC; Gomes MG
    Vaccine; 2008 May; 26(19):2418-27. PubMed ID: 18400341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.